{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T11:32:39Z","timestamp":1761823959346},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","worldneurosurgery.org","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["World Neurosurgery"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.wneu.2017.10.043","type":"journal-article","created":{"date-parts":[[2017,10,17]],"date-time":"2017-10-17T14:46:21Z","timestamp":1508251581000},"page":"432-435","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Safe Burr Hole Surgery for Chronic Subdural Hematoma Using Dabigatran with Idarucizumab"],"prefix":"10.1016","volume":"109","author":[{"given":"Nobuhiko","family":"Arai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yutaka","family":"Mine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Kagami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michiyuki","family":"Maruyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Daikoh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makoto","family":"Inaba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.wneu.2017.10.043_bib1","first-page":"263","article-title":"Demographics and prevalent risk factors of chronic subdural haematoma: results of a large single-center cohort study","volume":"27","author":"Haechli","year":"2004","journal-title":"Neurosurg Rev"},{"key":"10.1016\/j.wneu.2017.10.043_bib2","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1001\/jama.2017.0639","article-title":"Association of antithrombotic drug use with subdural hematoma risk","volume":"317","author":"Gaist","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.wneu.2017.10.043_bib3","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.2146\/ajhp160756","article-title":"Trends in utilization of warfarin and direct oral anticoagulants in older adult patients with atrial fibrillation","volume":"74","author":"Alalwan","year":"2017","journal-title":"Am J Health-Sys Pharm"},{"key":"10.1016\/j.wneu.2017.10.043_bib4","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/j.amjcard.2017.05.055","article-title":"Changes in use of anticoagulation in patients with atrial fibrillation within a primary care network associated with the introduction of direct oral anticoagulants","volume":"120","author":"Ashburmer","year":"2017","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.wneu.2017.10.043_bib5","doi-asserted-by":"crossref","first-page":"72","DOI":"10.3171\/2010.8.JNS10298","article-title":"Chronic subdural hematoma in the elderly: not a benign disease","volume":"114","author":"Miranda","year":"2011","journal-title":"J\u00a0Neurosurg"},{"key":"10.1016\/j.wneu.2017.10.043_bib6","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1212\/WNL.0000000000003918","article-title":"Anticoagulant and antiplatelet use in seniors with chronic subdural hematoma","volume":"88","author":"Nathan","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.wneu.2017.10.043_bib7","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1136\/jcp.2003.008904","article-title":"Warfarin reversal","volume":"57","author":"Hanley","year":"2004","journal-title":"J\u00a0Clin Pathol"},{"key":"10.1016\/j.wneu.2017.10.043_bib8","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1111\/j.1538-7836.2012.04859.x","article-title":"Reversal of dabigatran anticoagulation by prothrombin complex concentrate (Beriplex P\/N) in a rabbit model","volume":"10","author":"Pragst","year":"2012","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.wneu.2017.10.043_bib9","doi-asserted-by":"crossref","first-page":"3554","DOI":"10.1182\/blood-2012-11-468207","article-title":"Specific antidote for dabigatran: functional and structural characterization","volume":"121","author":"Schuele","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.wneu.2017.10.043_bib10","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1056\/NEJMoa1502000","article-title":"Idarucizumab for dabigatran reversal","volume":"373","author":"Pollack","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.wneu.2017.10.043_bib11","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1001\/jama.285.22.2864","article-title":"Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation","volume":"285","author":"Gage","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.wneu.2017.10.043_bib12","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1161\/STROKEAHA.112.650614","article-title":"Intracranial hemorrhage in atrial fibrillation patients during anticoagulation with warfarin or dabigatran: the RE-LY trial","volume":"43","author":"Hart","year":"2012","journal-title":"Stroke"},{"key":"10.1016\/j.wneu.2017.10.043_bib13","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1056\/NEJMoa1107039","article-title":"Apixaban versus warfarin in patients with atrial fibrillation","volume":"15","author":"Granger","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.wneu.2017.10.043_bib14","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1056\/NEJMoa1310907","article-title":"Edoxaban versus warfarin in patients with atrial fibrillation","volume":"28","author":"Giugliano","year":"2013","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.wneu.2017.10.043_bib15","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/S0140-6736(15)60732-2","article-title":"Safety, tolerability, and efficacy of idarucizumab for the reversal of the anticoagulant effect of dabigatran in healthy male volunteers: a randomised, placebo-controlled, double-blind phase 1 trial","volume":"386","author":"Glund","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.wneu.2017.10.043_bib16","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1007\/s11239-017-1476-2","article-title":"Real-life experience with the specific reversal agent idarucizumab for the management of emergency situations in dabigatran-treated patients: a series of 11 cases","volume":"43","author":"Vosko","year":"2017","journal-title":"J\u00a0Thromb Thrombolyis"},{"key":"10.1016\/j.wneu.2017.10.043_bib17","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1002\/ccr3.839","article-title":"Real-world use of idarucizumab for dabigatran reversal in three cases of serious bleeding","volume":"5","author":"Gendron","year":"2017","journal-title":"Clin Case Rep"},{"key":"10.1016\/j.wneu.2017.10.043_bib18","doi-asserted-by":"crossref","first-page":"68","DOI":"10.20452\/pamw.3918","article-title":"Successful use of idarucizumab as a reversal agent for dabigatran in a patient with acute dissected aortic aneurysm","volume":"127","author":"Tomaszuk-Kazberuk","year":"2017","journal-title":"Polish Arch Intern Med"},{"key":"10.1016\/j.wneu.2017.10.043_bib19","first-page":"227","article-title":"Reversal of anticoagulation with dabigatran in an 82-year-old patient with traumatic retroperitoneal arterial bleeding using the new antidote idarucizumab: a case report","volume":"7","author":"Hofer","year":"2016","journal-title":"Case Rep"},{"key":"10.1016\/j.wneu.2017.10.043_bib20","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1111\/jth.13227","article-title":"When and how to use antidotes for the reversal of direct oral anticoagulants: guidance from the SSC of the ISTH","volume":"14","author":"Levy","year":"2016","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.wneu.2017.10.043_bib21","doi-asserted-by":"crossref","first-page":"750","DOI":"10.3171\/2015.2.JNS141889","article-title":"Timing of the resumption of antithrombotic agents following surgical evacuation of chronic subdural hematomas: a retrospective cohort study","volume":"124","author":"Guha","year":"2016","journal-title":"J\u00a0Neurosurg"},{"key":"10.1016\/j.wneu.2017.10.043_bib22","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1136\/jnnp.48.1.58","article-title":"Correlation between plasma and CT findings in head injury","volume":"48","author":"Ueda","year":"1985","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"}],"container-title":["World Neurosurgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878875017317709?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878875017317709?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,26]],"date-time":"2018-08-26T21:10:16Z","timestamp":1535317816000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878875017317709"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":22,"alternative-id":["S1878875017317709"],"URL":"https:\/\/doi.org\/10.1016\/j.wneu.2017.10.043","relation":{},"ISSN":["1878-8750"],"issn-type":[{"value":"1878-8750","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safe Burr Hole Surgery for Chronic Subdural Hematoma Using Dabigatran with Idarucizumab","name":"articletitle","label":"Article Title"},{"value":"World Neurosurgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.wneu.2017.10.043","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}